These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11402938)

  • 21. Phase II trial of gemcitabine in advanced non-small-cell lung cancer.
    Malayeri R; Ulsperger E; Baumgartner G; Forstner B; Aigner K; Hubner M; Kummer F; Krajnik G; Zöchbauer S; Krejcy K; Huber H; Pirker R
    Wien Klin Wochenschr; 1997 Sep; 109(17):688-91. PubMed ID: 9331958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse alveolar damage in a patient treated with gemcitabine.
    Marruchella A; Fiorenzano G; Merizzi A; Rossi G; Chiodera PL
    Eur Respir J; 1998 Feb; 11(2):504-6. PubMed ID: 9551762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
    Fossella FV; Lippman SM; Shin DM; Tarassoff P; Calayag-Jung M; Perez-Soler R; Lee JS; Murphy WK; Glisson B; Rivera E; Hong WK
    J Clin Oncol; 1997 Jan; 15(1):310-6. PubMed ID: 8996158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
    J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer.
    van Putten JW; Baas P; Codrington H; Kwa HB; Muller M; Aaronson N; Groen HJ
    Lung Cancer; 2001; 33(2-3):289-98. PubMed ID: 11551424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).
    Ferrigno D; Buccheri G;
    Lung Cancer; 2004 Sep; 45(3):373-80. PubMed ID: 15301878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
    Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P
    Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of gemcitabine in combination with cisplatin in a randomized study of untreated patients with advanced non-small-cell lung carcinoma].
    Mehić B; Zutić H; Dizdarević Z; Lomigorić J
    Med Arh; 2004; 58(1):11-3. PubMed ID: 15017896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report.
    Shepherd FA; Burkes R; Cormier Y; Crump M; Feld R; Strack T
    Lung Cancer; 1996 Feb; 14(1):135-44. PubMed ID: 8696717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
    Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P
    Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy.
    Gurumurthy M; Koh P; Singh R; Bhide A; Satodia P; Hocking M; Anbarasu A; Wood LE
    J Perinatol; 2009 Jan; 29(1):63-5. PubMed ID: 19112460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe pulmonary toxicity in a patient treated with gemcitabine.
    Rosado MF; Kett DH; Schein RM; Baraona FJ; Sridhar KS
    Am J Clin Oncol; 2002 Feb; 25(1):31-3. PubMed ID: 11823691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy in locally advanced non-small cell lung cancer.
    Hamouda W; Dorgham Y; Yosry A; Abdel Wahab M
    Gulf J Oncolog; 2007 Jul; (2):55-64. PubMed ID: 20084725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.
    D'Angelillo RM; Trodella L; Ciresa M; Cellini F; Fiore M; Greco C; Pompeo E; Mineo TC; Paleari L; Granone P; Ramella S; Cesario A
    J Thorac Oncol; 2009 Dec; 4(12):1517-23. PubMed ID: 19875976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer].
    Li GZ; Zhang SH; Zhang Z; Wang RL
    Ai Zheng; 2007 Dec; 26(12):1377-80. PubMed ID: 18076806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More is better but ... how is best: are milligrams over hours better than grams over minutes? The case of gemcitabine.
    Pollera CF
    J Clin Oncol; 1997 May; 15(5):2172-4. PubMed ID: 9164234
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer.
    Blackstock AW; Ho C; Butler J; Fletcher-Steede J; Case LD; Hinson W; Miller AA
    J Thorac Oncol; 2006 Jun; 1(5):434-40. PubMed ID: 17409896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
    Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.